This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) rallied 2.62% to $17.22 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 33,597.92 and the NASDAQ Composite Index falling 0.51% to 10,958.55. Novavax Inc. closed $219.28 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.61% to $177.17, Pfizer Inc. (PFE) rose 1.07% to $50.24, and Merck & Co. Inc. (MRK) rose 1.06% to $110.09. Trading volume (3.2 M) remained 1.9 million below its 50-day average volume of 5.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 7, 2022.
(END) Dow Jones Newswires
December 07, 2022 17:24 ET (22:24 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.